RR\ID is an open-access overlay journal that accelerates peer review of important infectious disease-related research preprints. We are an evolution of Rapid Reviews: COVID-19 (RR\C19), which won the 2022 PROSE Award for Innovation in Journal Publishing for introducing a new peer review model facilitating rapid publishing of COVID-19-related research preprints. RR\ID expands beyond COVID-19 to advance our understanding of infectious diseases, leaning on a similar “curate, review, publish” model. RR\ID aims to prevent the dissemination of false/misleading scientific information and accelerate the validation and diffusion of robust findings. RR\ID aims to increase the application of science for the common good, responding to infectious disease challenges throughout the world.
The Association of American Publishers has awarded RR:C19 the 2022 PROSE award for Innovation in Journal Publishing. We are truly grateful for this distinguished acknowledgement!
Reviewers: J Shang (Suzhou Inst. of Systems Medicine) |📘📘📘📘📘 • C Vogles (Yale) |📘📘📘📘📘 • J Lu (Peking University) |📗📗📗📗◻️ • R Kumar (Magadh University) |📗📗📗📗◻️ • U Tatu & A Kumar (Indian Institute of Science) |📒📒📒 ◻️◻️ • S Ali (Aliah University) |📘📘📘📘📘
Reviewers: J Dieleman (University of Washington) | 📗📗📗📗◻️ • F Dun-Dery (University of Calgary) | 📒📒📒◻️◻️ • E M Maffioli (University of Michigan) | 📗📗📗📗◻️
RR\ID is published by The MIT Press with generous support from the Gates Foundation, the Patrick J. McGovern Foundation and edited by a team from UC Berkeley.
